total-body irradiation (TBI)

RADIATION7 trials

Conditions

Acute LeukemiaAcute Lymphocytic LeukemiaAcute Myelogenous LeukemiaChronic LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaChronic Myeloproliferative DisordersGraft Versus Host Disease

Phase 1

Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

TerminatedNCT02057770

Washington University School of MedicineLeukemia, Myeloid, Acute

Start: 2014-02-28End: 2018-03-23Updated: 2018-10-12

Phase 2

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

CompletedNCT00571662

University of NebraskaAcute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia +6

Start: 2000-12-08End: 2008-12-30Updated: 2023-10-24

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

TerminatedNCT00589602

The Cleveland ClinicChronic Myeloproliferative Disorders, Leukemia, Lymphoma +4

Start: 2004-01-31End: 2014-12-31Updated: 2017-05-30

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

TerminatedNCT00914940

Fred Hutchinson Cancer CenterGraft Versus Host Disease, Leukemia, Myelodysplastic Syndromes

Start: 2009-12-17End: 2020-05-26Updated: 2020-08-20

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruitingNCT01746849

Memorial Sloan Kettering Cancer CenterLeukemia, Multiple Myeloma, Myelodysplastic Syndrome +1

Start: 2012-12-31End: 2026-12-31Updated: 2026-01-07

Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor

CompletedNCT01982682

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityHematopoietic/Lymphoid Cancer

Start: 2013-11-04End: 2017-03-27Updated: 2025-04-30

Unknown Phase

Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

TerminatedNCT01598025

Memorial Sloan Kettering Cancer CenterAcute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome +1

Start: 2012-05-02End: 2017-10-16Updated: 2018-08-09

Related Papers

Zinc Status Affects T Cell Reconstitution in Patients Receiving Naïve T Cell Depleted Allogeneic HSCT